Vertex reports third quarter 2022 financial results

Boston--(business wire)--vertex pharmaceuticals incorporated (nasdaq: vrtx) today reported consolidated financial results for the third quarter ended september 30, 2022 and increased its full year 2022 revenue guidance.
VRTX Ratings Summary
VRTX Quant Ranking